The PI3K/Akt pathway is considered one of the most important oncogenic pathways in human cancers, with ZIP10 driving osteosarcoma proliferation and chemoresistance through activation of the PI3K/AKT pathway mediated by ITGA10 and highly correlated with clinical prognosis (57, 58). This evidence concerns the gene SLC39A10 and cancer.